Melatonin inhibits nuclear factor-kappa B (NF-κB)/cyclic AMP response element-binding protein (CREB), contributing to CAVD progression. The gene discussed is NFKB1; the disease is congenital bilateral aplasia of vas deferens from CFTR mutation.